S6045 | Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry | Smith & Moses
S6045Senate
Official Title
Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry
2021-2022 SessionPete HarckhamAffects: Public Health Law